IDEXX Laboratories, Inc. (LON: 0J8P)

IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 29, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Cash & Equivalents	308.64	453.93	112.55	144.45	383.93	90.33
Cash & Short-Term Investments	308.64	453.93	112.55	144.45	383.93	90.33
Cash Growth	-6.95%	303.33%	-22.09%	-62.37%	325.05%	-27.04%
Accounts Receivable	572.67	512.56	442.47	406.12	355.27	286.97
Other Receivables	14.41	16.97	48.43	19.46	19.48	20.52
Receivables	587.07	529.53	490.9	425.58	374.74	307.49
Inventory	389.8	380.28	367.82	269.03	209.87	195.02
Prepaid Expenses	57.22	48.37	41.74	42	34.56	31.99
Other Current Assets	91.01	83.14	88.46	74.59	59.64	54.82
Total Current Assets	1,434	1,495	1,101	955.66	1,063	679.64
Property, Plant & Equipment	838.8	817.68	768.09	692.77	646.34	614.45
Long-Term Investments	30	30.25	30.25	5.25	-	-
Goodwill	412.07	365.96	361.8	359.35	243.35	239.72
Other Intangible Assets	106.89	84.5	97.67	99.04	52.54	58.47
Long-Term Accounts Receivable	185.86	167.96	148.97	122.16	91.68	66.23
Long-Term Deferred Tax Assets	134.68	107.36	55.22	24.78	31.55	8.1
Long-Term Deferred Charges	-	-	-	122.41	116.09	108.56
Other Long-Term Assets	208.73	190.96	183.29	55.8	50.28	57.31
Total Assets	3,351	3,260	2,747	2,437	2,295	1,832
Accounts Payable	110.6	110.64	110.22	116.14	74.56	72.17
Accrued Expenses	410.01	372.36	364.69	395.77	342.87	273.66
Short-Term Debt	250	250	579	73.5	-	-
Current Portion of Long-Term Debt	99.14	75	74.98	75	49.99	288.77
Current Portion of Leases	20.96	19.8	20.43	19.93	17.73	15.28
Current Income Taxes Payable	80.07	86.55	48.55	42.61	42.68	31.11
Current Unearned Revenue	38.43	37.2	37.94	40.03	42.57	41.46
Other Current Liabilities	-	-	-	0.6	12.37	2.89
Total Current Liabilities	1,009	951.55	1,236	763.58	582.76	725.34
Long-Term Debt	524.76	622.88	694.39	775.21	858.49	698.91
Long-Term Leases	103.42	99.67	101.24	87.38	77.04	67.47
Long-Term Unearned Revenue	26.77	28.53	30.86	41.17	46.16	48.74
Long-Term Deferred Tax Liabilities	5.66	7.24	8.15	8.94	11.71	33.02
Other Long-Term Liabilities	62.88	65.53	67.59	70.94	85.6	81.16
Total Liabilities	1,733	1,775	2,138	1,747	1,662	1,655
Common Stock	10.77	10.75	10.72	10.69	10.65	10.57
Additional Paid-In Capital	1,646	1,570	1,463	1,377	1,295	1,214
Retained Earnings	5,116	4,445	3,600	2,920	2,176	1,596
Treasury Stock	-5,085	-4,475	-4,392	-3,571	-2,800	-2,601
Comprehensive Income & Other	-70.09	-65.68	-72.61	-47.77	-49.11	-41.72
Total Common Equity	1,618	1,485	608.74	689.99	632.09	177.47
Minority Interest	-	-	-	-	0.71	0.35
Shareholders' Equity	1,618	1,485	608.74	689.99	632.8	177.83
Total Liabilities & Equity	3,351	3,260	2,747	2,437	2,295	1,832
Total Debt	998.28	1,067	1,470	1,031	1,003	1,070
Net Cash (Debt)	-689.64	-613.42	-1,357	-886.56	-619.32	-980.1
Net Cash Per Share	-8.25	-7.30	-16.05	-10.24	-7.14	-11.20
Filing Date Shares Outstanding	81.88	83.09	82.9	84.25	85.43	85.33
Total Common Shares Outstanding	82.04	83.03	82.89	84.56	85.45	85.47
Working Capital	424.52	543.71	-134.33	192.08	479.98	-45.7
Book Value Per Share	19.72	17.88	7.34	8.16	7.40	2.08
Tangible Book Value	1,099	1,034	149.27	231.61	336.2	-120.72
Tangible Book Value Per Share	13.40	12.45	1.80	2.74	3.93	-1.41
Land	-	22.4	22.22	22.64	13.98	8.73
Buildings	-	432.04	356.05	329.09	319.38	249.92
Machinery	-	837.15	772.56	728.74	686.49	616.43
Construction In Progress	-	79.06	97.31	62.34	39.76	103.2
Leasehold Improvements	-	116.35	107.25	93.25	82.46	74.6

Source: S&P Capital IQ. Standard template. Financial Sources.